Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age.

MLA

Kusumi, Kirsten, et al. “Beneficial Effects of Intravenous Pamidronate Treatment in Children with Osteogenesis Imperfecta under 24 Months of Age.” Journal of Bone & Mineral Metabolism, vol. 33, no. 5, Sept. 2015, pp. 560–68. EBSCOhost, https://doi.org/10.1007/s00774-014-0618-2.

APA

Kusumi, K., Ayoob, R., Bowden, S., Ingraham, S., & Mahan, J. (2015). Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age. Journal of Bone & Mineral Metabolism, 33(5), 560–568. https://doi.org/10.1007/s00774-014-0618-2

Chicago

Kusumi, Kirsten, Rose Ayoob, Sasigarn Bowden, Susan Ingraham, and John Mahan. 2015. “Beneficial Effects of Intravenous Pamidronate Treatment in Children with Osteogenesis Imperfecta under 24 Months of Age.” Journal of Bone & Mineral Metabolism 33 (5): 560–68. doi:10.1007/s00774-014-0618-2.